Octrooien

The European Unitary Patent System looks to be back on track again

Jul 15, 2021 | Tags: Octrooien , IP Insight

Using disclosures to your advantage

Jul 14, 2021 | Tags: Octrooien , IP Insight

NFTs – a slam dunk or a sticky wicket for brand owners?

Jul 6, 2021 | Tags: Octrooien , Merken , IP Insight

Disclosures

Jul 5, 2021 | Tags: Octrooien , IP Insight

Covid vaccine patent waivers – the opinion of our vaccine IP specialist

May 6, 2021 | Tags: Octrooien , Biosciences , IP Insight

Where to Obtain Patent Protection?

Mar 9, 2021 | Tags: Octrooien , IP Insight

Chemists are in the driving seat of electric vehicle development

Feb 25, 2021 | Tags: Octrooien , Energy and environment , Battery technology

Freedom to Operate – What does it mean and a look at some different approaches

Jan 25, 2021 | Tags: Octrooien , IP Insight

Medical inventions – a European perspective

Jan 19, 2021 | Tags: Octrooien , Biosciences , IP Insight

Expediting Patent Prosecution – Use of International Examination

Nov 24, 2020 | Tags: Octrooien , IP Insight

Videoconference Hearings at the EPO – A Game-Changing Announcement from the EPO

Nov 11, 2020 | Tags: Octrooien , IP Insight

The Unitary Patent and Unified Patent Court system – an update

Jul 21, 2020 | Tags: Octrooien , IP Insight

No SPCs for new therapeutic applications of old drugs – CJEU overturns Neurim

Jul 16, 2020 | Tags: Octrooien , Biosciences , IP Insight

Money for old dope

Jul 15, 2020 | Tags: Octrooien , IP Insight

“No Patents On Peppers”… or any plants or animals exclusively obtained by means of an essentially biological process

May 27, 2020 | Tags: Octrooien , Biosciences , Food and drink , IP Insight

Mobile apps at the forefront of the Covid-19 fight

May 13, 2020 | Tags: Octrooien , Merken , Biosciences , Modellen , Software